Suchergebnisse - "Amiot, Aurélien"

PubPharm (223)

61

Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2021

von Laharie, D. | Bourreille, A. | Branche, J. | +26

62

Editorial : determining disability in inflammatory bowel disease-"See(k) and you shall find". Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Tannoury, J. | Amiot, A.

CommentOn: Aliment Pharmacol Ther. 2021 May;53(10):1098-1107. - PMID 33817819

63

The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2021

von Tadbiri, S. | Nachury, M. | Bouhnik, Y. | +109

64

Determinants of IBD-related disability : a cross-sectional survey from the GETAID

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Tannoury, J. | Nachury, M. | Martins, C. | +23

CommentIn: Aliment Pharmacol Ther. 2021 Jun;53(12):1323. - PMID 34029412

65

Outcomes after double switching from originator Infliximab to biosimilar CT-P13 and biosimilar SB2 in patients with inflammatory bowel disease : a 12-month prospective cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Trystram, N. | Abitbol, V. | Tannoury, J. | +8

CommentIn: Aliment Pharmacol Ther. 2021 May;53(9):1038-1039. - PMID 33831242

66

An Anti-migration Self-expandable and Removable Metal Stent for Crohn's Disease Strictures : A Nationwide Study From GETAID and SFED

enthalten in: Journal of Crohn's & colitis | 2021

von Attar, A. | Branche, J. | Coron, E. | +11

67

Patients' real-world experience with inflammatory bowel disease : A cross-sectional survey in tertiary care centres from the GETAID group

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2021

von Nachury, M. | Bouhnik, Y. | Serrero, M. | +102

68

Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease : a multicentre cohort study from the GETAID

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Broussard, D. | Rivière, P. | Bonnet, J. | +20

CommentIn: Aliment Pharmacol Ther. 2021 Feb;53(3):454-455. - PMID 33428256

69

Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients : a multicentre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Wils, P. | Seksik, P. | Stefanescu, C. | +68

CommentIn: Aliment Pharmacol Ther. 2021 Feb;53(3):450-451. - PMID 33428251

70

Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma : A Case-Control Comparison With Intravenous Rituximab

enthalten in: Clinical lymphoma, myeloma & leukemia | 2021

von Rotkopf, H. | Lévy, M. | Copie-Bergman, C. | +10